Recently, de novo and inherited heterozygous variants in KCNA2 gene have been identified in patients presenting with early infantile epileptic encephalopathy, intellectual disability, delayed speech, development delay and ataxia [10,11]. The gene discussed is KCNA2; the disease is Ataxia.